Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
58
NMPA:58
Drug Approvals
Bortezomib for Injection
- Product Name
- 注射用硼替佐米
- Approval Number
- 国药准字H20253697
- Approval Date
- Mar 25, 2025
NMPA
Sarcandra dispersion tablets
- Product Name
- 肿节风分散片
- Approval Number
- 国药准字Z20090290
- Approval Date
- Mar 15, 2024
NMPA
Meglumine Adenosine Cyclophosphate Injection
- Product Name
- 环磷腺苷葡胺注射液
- Approval Number
- 国药准字H22024608
- Approval Date
- Mar 15, 2024
NMPA
Ligustrazine Hydrochloride Injection
- Product Name
- 盐酸川芎嗪注射液
- Approval Number
- 国药准字H22025223
- Approval Date
- Mar 15, 2024
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20198009
- Approval Date
- Feb 20, 2024
NMPA
Alprostadil for Injection
- Product Name
- 注射用前列地尔
- Approval Number
- 国药准字H22026343
- Approval Date
- Feb 2, 2024
NMPA
Alprostadil for Injection
- Product Name
- 注射用前列地尔
- Approval Number
- 国药准字H22026344
- Approval Date
- Feb 2, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found